Janus Henderson Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$275M Buy
1,972,639
+110,525
+6% +$15.5M 0.13% 156
2025
Q4
$229M Buy
1,862,114
+203,652
+12% +$24.7M 0.1% 179
2025
Q3
$184M Buy
1,658,462
+526,945
+47% +$59.9M 0.08% 196
2025
Q2
$125M Buy
1,131,517
+403,100
+55% +$42.9M 0.06% 237
2025
Q1
$81.4M Sell
728,417
-567,660
-44% -$58.6M 0.04% 290
2024
Q4
$120M Sell
1,296,077
-465,484
-26% -$41.9M 0.06% 256
2024
Q3
$148M Buy
1,761,561
+98,067
+6% +$7.48M 0.08% 224
2024
Q2
$114M Sell
1,663,494
-50,249
-3% -$3.35M 0.06% 247
2024
Q1
$126M Sell
1,713,743
-56,157
-3% -$4.32M 0.07% 237
2023
Q4
$143M Sell
1,769,900
-118,742
-6% -$9.24M 0.09% 215
2023
Q3
$142M Sell
1,888,642
-28,925
-2% -$2.22M 0.09% 203
2023
Q2
$148M Buy
1,917,567
+310,811
+19% +$24.8M 0.09% 202
2023
Q1
$133M Sell
1,606,756
-431,194
-21% -$35.7M 0.09% 213
2022
Q4
$175M Sell
2,037,950
-2,226,690
-52% -$176M 0.13% 176
2022
Q3
$263M Buy
4,264,640
+1,348,727
+46% +$85M 0.1% 202
2022
Q2
$180M Sell
2,915,913
-2,399,373
-45% -$149M 0.12% 181
2022
Q1
$316M Sell
5,315,286
-22,544
-0.4% -$1.44M 0.15% 157
2021
Q4
$388M Sell
5,337,830
-132,509
-2% -$9.13M 0.16% 145
2021
Q3
$382M Buy
5,470,339
+233,792
+4% +$16.4M 0.17% 141
2021
Q2
$361M Buy
5,236,547
+775,016
+17% +$51.8M 0.15% 153
2021
Q1
$288M Sell
4,461,531
-509,988
-10% -$32.9M 0.13% 181
2020
Q4
$290M Sell
4,971,519
-307,322
-6% -$18.5M 0.13% 169
2020
Q3
$334M Sell
5,278,841
-576,816
-10% -$40M 0.17% 132
2020
Q2
$451M Buy
5,855,657
+63,922
+1% +$4.9M 0.25% 89
2020
Q1
$433M Sell
5,791,735
-823,733
-12% -$56.9M 0.3% 74
2019
Q4
$430M Buy
6,615,468
+1,392,639
+27% +$90.7M 0.22% 106
2019
Q3
$331M Buy
5,222,829
+767,158
+17% +$50.1M 0.18% 134
2019
Q2
$301M Sell
4,455,671
-525,209
-11% -$34.6M 0.16% 153
2019
Q1
$324M Sell
4,980,880
-976,622
-16% -$64.9M 0.18% 140
2018
Q4
$373M Buy
5,957,502
+2,292,531
+63% +$160M 0.24% 106
2018
Q3
$283M Buy
3,664,971
+522,519
+17% +$39.5M 0.15% 172
2018
Q2
$223M Buy
3,142,452
+442,801
+16% +$31.3M 0.13% 205
2018
Q1
$204M Buy
2,699,651
+848,423
+46% +$67.4M 0.12% 213
2017
Q4
$133M Buy
1,851,228
+69,321
+4% +$5.26M 0.08% 293
2017
Q3
$144M Buy
1,781,907
+30,713
+2% +$2.35M 0.09% 267
2017
Q2
$124M Buy
1,751,194
+1,568,191
+857% +$104M 0.08% 294
2017
Q1
$12.4M Sell
183,003
-1,610
-0.9% -$113K 0.09% 251
2016
Q4
$13.2M Buy
184,613
+14,234
+8% +$1.06M 0.1% 244
2016
Q3
$13.5M Buy
170,379
+253
+0.1% +$20.6K 0.1% 242
2016
Q2
$14.2M Sell
170,126
-21,063
-11% -$1.87M 0.12% 218
2016
Q1
$17.6M Buy
191,189
+1,571
+0.8% +$142K 0.14% 178
2015
Q4
$19.2M Sell
189,618
-5,817
-3% -$605K 0.15% 164
2015
Q3
$19.2M Sell
195,435
-5,142
-3% -$571K 0.17% 158
2015
Q2
$23.5M Sell
200,577
-149,549
-43% -$16.3M 0.18% 150
2015
Q1
$34.4M Sell
350,126
-941,544
-73% -$95.6M 0.27% 100
2014
Q4
$122M Sell
1,291,670
-557,608
-30% -$57.7M 0.88% 15
2014
Q3
$197M Sell
1,849,278
-224,441
-11% -$22M 1.85% 6
2014
Q2
$172M Buy
2,073,719
+763,883
+58% +$59.5M 1.61% 6
2014
Q1
$92.8M Buy
1,309,836
+511,384
+64% +$40.1M 0.9% 21
2013
Q4
$60M Buy
798,452
+9,052
+1% +$630K 0.61% 32
2013
Q3
$49.6M Sell
789,400
-152,487
-16% -$9.11M 0.55% 39
2013
Q2
$48.7M Buy
+941,887
New +$49.1M 0.57% 32

Other funds holding GILD

Janus Henderson Group's GILD Position: Q1 2026 in Review

Janus Henderson Group increased its Gilead Sciences (GILD) stake by 5.9% in Q1 2026, buying an estimated $15.5M and bringing the position to 1,972,639 shares worth $275M. The position accounts for 0.13% of the portfolio, ranked #156.

Janus Henderson Group first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $451M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Janus Henderson Group held 1,972,639 shares of Gilead Sciences worth $275M as of Q1 2026.
  • Janus Henderson Group bought 110,525 Gilead Sciences shares in Q1 2026, an estimated $15.5M.
  • Gilead Sciences made up 0.13% of Janus Henderson Group's portfolio in Q1 2026, its #156 holding.
  • Janus Henderson Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Janus Henderson Group's Gilead Sciences position peaked at $451M in Q2 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.